What determines patient preferences for treating low risk basal cell carcinoma when comparing surgery vs imiquimod? A discrete choice experiment survey from the SINS trial

BACKGROUND: The SINS trial (Controlled Clinical Trials ISRCTN48755084; Eudract No. 2004-004506-24) is a randomised controlled trial evaluating long term success of excisional surgery vs. imiquimod 5% cream for low risk nodular and superficial basal cell carcinoma (BCC). The trial included a discrete...

Descripción completa

Detalles Bibliográficos
Autores principales: Tinelli, Michela, Ozolins, Mara, Bath-Hextall, Fiona, Williams, Hywel C
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532314/
https://www.ncbi.nlm.nih.gov/pubmed/23035730
http://dx.doi.org/10.1186/1471-5945-12-19

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3532314/
https://www.ncbi.nlm.nih.gov/pubmed/23035730
http://dx.doi.org/10.1186/1471-5945-12-19

Ejemplares similares